Clinical trials are designed to evaluate the effectiveness of new treatment interventions. The objective of these clinical trials is to test new therapies in patients who have cancer. Patients participate in clinical trials for several reasons, including:
- The potential to benefit from a new drug or treatment procedure
- Improved management of symptoms resulting from treatment or cancer
- The opportunity to directly contribute to improving the understanding of how to treat a cancer and ultimately, benefit other patients
Patients who participate in clinical trials receive either a promising new treatment or the best available conventional treatment. If a new treatment option is proven to work, patients who are participating in the clinical trial will be among the first to benefit. While there is no guarantee that any treatments will be successful, clinical trials have been proven to offer some of the most effective cancer treatments currently available today.
Pacific Cancer Care has had a first in world clinical trial, meaning we were the first site in the world to offer the trial. Further, PCC has had the first patient in the world enrolled on another major trial. We strive to bring new and innovative therapies to the local area so we can allow our patients access to those treatments months, or even years, before they are commercially available. Our affiliation with the Dana-Farber Cancer Institute, a world-renowned research center, as well as the Parker Institute for Cancer Immunotherapy, has given us the opportunity to be the only site on the west coast to offer some exciting trials. We also have close working relationships with Stanford University, UCSF and UC Davis, and we take advantage of those connections on a daily basis.
If you are interested in learning more about our clinical trials program, ask your doctor or call us at 831-375-4105 and ask to speak with a member of our research team.